Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.
Mol Genet Metab
; 119(1-2): 151-9, 2016 09.
Article
en En
| MEDLINE
| ID: mdl-27510433
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Fabry
/
Alfa-Galactosidasa
/
Accidente Cerebrovascular
/
Isoenzimas
/
Enfermedades Renales
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Límite:
Adult
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Mol Genet Metab
Asunto de la revista:
BIOLOGIA MOLECULAR
/
BIOQUIMICA
/
METABOLISMO
Año:
2016
Tipo del documento:
Article